Clinical Trial Update: Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating myeloablative consolidation therapy with tandem autologous stem cell rescue in high-risk neurobl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Neuroblastoma | Phase 2 | Status: RECRUITING